Intracervical Lidocaine Versus Intramuscular Diclofenac for Pain Relief in HSG in a Tertiary Hospital in Kano
Female Infertility of Tubal Origin
About this trial
This is an interventional diagnostic trial for Female Infertility of Tubal Origin focused on measuring Hysterosalpingography, Pain relief, Infertility, Intracervical block, Diclofenac
Eligibility Criteria
Inclusion Criteria:
- All women with infertility who will be undergoing a hysterosalpingography, and must have given consent will be recruited into the study
Exclusion Criteria:
- History of any allergies to local anaesthetics, radio-opaque dye, or anti-inflammatory medications
- All patients with active pelvic inflammatory diseases
- All patients with chronic pelvic pain
- Patients with history of cervical surgery
- Other indications for hysterosalpingography like Ashermans syndrome, congenital uterine anomalies
Sites / Locations
- Aminu Kano Teaching HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intracervical lidocaine
Intramuscular Diclofenac
This group will comprise of patients that will receive the intracervical block. The study group will receive a total of 60 mg (6 mL) of 1% lidocaine to be injected at four points (12, 4, 6, and 8 o'clock) circumferentially into the cervix (1.5 mL at each point) 5 minutes before proceeding with the hysterosalpingogram.
This group will comprise of patients that will receive intramuscular diclofenac potassium 75mg 30 minutes before proceeding with the hysterosalpingogram.